|
Lipids and Lipid Disorders
Citations 1-10 of 259 total displayed.
|
Most recent content
(28 Oct 2009):
|
- Original Contributions
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- Christoph U. Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M. Kane; Anil K. Malhotra
JAMA 2009; 302: 1765-1773.
[Abstract]
[Full text]
[PDF]
[ eTables ]
- Editorials
Implications of Marked Weight Gain Associated With Atypical Antipsychotic Medications in Children and Adolescents
- Christopher K. Varley; Jon McClellan
JAMA 2009; 302: 1811-1812.
[Extract]
[Full text]
[PDF]
|
Past content
(since Feb 1998):
|
- Letters
Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction—Reply
- Pia R. Kamstrup; Børge G. Nordestgaard
JAMA 2009; 302: 1645-a-1646-a.
[Extract]
[Full text]
[PDF]
- Letters
Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction
- Steven R. Jones; Roger S. Blumenthal
JAMA 2009; 302: 1645.
[Extract]
[Full text]
[PDF]
- Preliminary Communications
Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome
- Marietta Charakida; Christian Besler; Joana R. Batuca; Shirish Sangle; Susanna Marques; Miguel Sousa; Guosu Wang; Dimitris Tousoulis; Jose Delgado Alves; Stavros P. Loukogeorgakis; Charles Mackworth-Young; David D’Cruz; Thomas Luscher; Ulf Landmesser; John E. Deanfield
JAMA 2009; 302: 1210-1217.
[Abstract]
[Full text]
[PDF]
- Reviews
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- The Emerging Risk Factors Collaboration
JAMA 2009; 302: 412-423.
[Abstract]
[Full text]
[PDF]
[ eSupplement ]
- Letters
Carotid Atherosclerosis Progression and ACAT Inhibition
- Simon Dimmitt; Gerald Watts
JAMA 2009; 302: 255-a-256-a.
[Extract]
[Full text]
[PDF]
- Letters
Carotid Atherosclerosis Progression and ACAT Inhibition
- Paolo Parini; Mats Eriksson; Lawrence L. Rudel
JAMA 2009; 302: 255.
[Extract]
[Full text]
[PDF]
- Letters
Carotid Atherosclerosis Progression and ACAT Inhibition—Reply
- Raphaël Duivenvoorden; Eric de Groot; John J. P. Kastelein
JAMA 2009; 302: 256-257.
[Extract]
[Full text]
[PDF]
- Original Contributions
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- Pia R. Kamstrup; Anne Tybjærg-Hansen; Rolf Steffensen; Børge G. Nordestgaard
JAMA 2009; 301: 2331-2339.
[Abstract]
[Full text]
[PDF]
[ eAppendix ]
|
|
